{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T10:37:51Z","timestamp":1793529471655,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T00:00:00Z","timestamp":1412035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T00:00:00Z","timestamp":1412035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Prevalence of iron deficiency (ID) at intensive care (ICU) admission is around 25 to 40%. Blood losses are important during ICU stay, leading to iron losses, but prevalence of ID at ICU discharge is unknown. ID has been associated with fatigue and muscular weakness, and may thus impair post-ICU rehabilitation. This study assessed ID prevalence at ICU discharge, day 28 (D28) and six months (M6) after and its relation with fatigue.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We conducted this prospective, multicenter observational study at four University hospitals ICUs. Anemic (hemoglobin (Hb) less than 13 g\/dL in male and less than 12 g\/dL in female) critically ill adult patients hospitalized for at least five days had an iron profile taken at discharge, D28 and M6. ID was defined as ferritin less than 100 ng\/L or less than 300 ng\/L together with a transferrin saturation less than 20%. Fatigue was assessed by numerical scale and the Multidimensional Fatigue Inventory-20 questionnaire at D28 and M6 and muscular weakness by a hand grip test at ICU discharge.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Among 107 patients (men 77%, median (IQR) age 63 (48 to 73) years) who had a complete iron profile at ICU discharge, 9 (8.4%) had ID. At ICU discharge, their hemoglobin concentration (9.5 (87.7 to 10.3) versus 10.2 (92.2 to 11.7) g\/dL, <jats:italic>P<\/jats:italic> =0.09), hand grip strength (52.5 (30 to 65) versus 49.5 (15.5 to 67.7)% of normal value, <jats:italic>P<\/jats:italic> =0.61) and visual analog scale fatigue scale (57 (40 to 80) versus 60 (47.5 to 80)\/100, <jats:italic>P<\/jats:italic> =0.82) were not different from non-ID patients. At D28 (<jats:italic>n<\/jats:italic> =80 patients) and M6 (<jats:italic>n<\/jats:italic> =78 patients), ID prevalence increased (to 25 and 35% respectively) while anemia prevalence decreased (from 100% to 80 and 25% respectively, <jats:italic>P<\/jats:italic> &lt;0.0001). ID was associated with increased fatigue at D28, after adjustment for main confounding factors, including anemia (regression coefficient (95%CI), 3.19 (0.74 to 5.64), <jats:italic>P<\/jats:italic> =0.012). At M6, this association disappeared.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>The prevalence of ID increases from 8% at discharge to 35% six months after prolonged ICU stay (more than five days). ID was associated with increased fatigue, independently of anemia, at D28.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13054-014-0542-9","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T15:10:56Z","timestamp":1411571456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study"],"prefix":"10.1186","volume":"18","author":[{"given":"Sigismond","family":"Lasocki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Chudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Papet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Tartiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Roquilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Mimoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Malledant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Asehnoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Fran\u00e7ois","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the AtlanREA group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,30]]},"reference":[{"key":"542_CR1","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1001\/jama.288.12.1499","volume":"288","author":"JL Vincent","year":"2002","unstructured":"Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D: Anemia and blood transfusion in critically ill patients. JAMA. 2002, 288: 1499-1507. 10.1001\/jama.288.12.1499.","journal-title":"JAMA"},{"key":"542_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/01.CCM.0000104112.34142.79","volume":"32","author":"HL Corwin","year":"2004","unstructured":"Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ: The CRIT Study: anemia and blood transfusion in the critically ill\u2013current clinical practice in the United States. Crit Care Med. 2004, 32: 39-52. 10.1097\/01.CCM.0000104112.34142.79.","journal-title":"Crit Care Med"},{"key":"542_CR3","doi-asserted-by":"crossref","unstructured":"From the Centers for Disease Control and Prevention. Iron deficiency-United States, 1999-2000. JAMA 2002, 288:2114-2116.,","DOI":"10.1001\/jama.288.17.2114"},{"key":"542_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/cc2884","volume":"8","author":"M Piagnerelli","year":"2004","unstructured":"Piagnerelli M, Vincent JL: Role of iron in anaemic critically ill patients: it's time to investigate!. Crit Care. 2004, 8: 306-307. 10.1186\/cc2884.","journal-title":"Crit Care"},{"key":"542_CR5","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1097\/01.CCM.0000220495.10510.C1","volume":"34","author":"FM Pieracci","year":"2006","unstructured":"Pieracci FM, Barie PS: Diagnosis and management of iron-related anemias in critical illness. Crit Care Med. 2006, 34: 1898-1905. 10.1097\/01.CCM.0000220495.10510.C1.","journal-title":"Crit Care Med"},{"key":"542_CR6","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/ALN.0b013e3182065c57","volume":"114","author":"S Lasocki","year":"2011","unstructured":"Lasocki S, Longrois D, Montravers P, Beaumont C: Hepcidin and anemia of the critically ill patient. Anesthesiology. 2011, 114: 688-694. 10.1097\/ALN.0b013e3182065c57.","journal-title":"Anesthesiology"},{"key":"542_CR7","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(98)00088-9","volume":"352","author":"MC Bellamy","year":"1998","unstructured":"Bellamy MC, Gedney JA: Unrecognised iron deficiency in critical illness. Lancet. 1998, 352: 1903-10.1016\/S0140-6736(98)00088-9.","journal-title":"Lancet"},{"key":"542_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/ALN.0b013e3181d74f87","volume":"112","author":"R Fernandez","year":"2010","unstructured":"Fernandez R, Tubau I, Masip J, Munoz L, Roig I, Artigas A: Low reticulocyte hemoglobin content is associated with a higher blood transfusion rate in critically ill patients: a cohort study. Anesthesiology. 2010, 112: 1211-1215. 10.1097\/ALN.0b013e3181d74f87.","journal-title":"Anesthesiology"},{"key":"542_CR9","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s00134-010-1794-8","volume":"36","author":"S Lasocki","year":"2010","unstructured":"Lasocki S, Baron G, Driss F, Westerman M, Puy H, Boutron I, Beaumont C, Montravers P: Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med. 2010, 36: 1044-1048. 10.1007\/s00134-010-1794-8.","journal-title":"Intensive Care Med"},{"key":"542_CR10","first-page":"115","volume":"20","author":"M Munoz","year":"2005","unstructured":"Munoz M, Romero A, Morales M, Campos A, Garcia-Erce JA, Ramirez G: Iron metabolism, inflammation and anemia in critically ill patients. A cross-sectional study. Nutr Hosp. 2005, 20: 115-120.","journal-title":"Nutr Hosp"},{"key":"542_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/sur.2008.043","volume":"10","author":"FM Pieracci","year":"2009","unstructured":"Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS: Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect (Larchmt). 2009, 10: 9-19. 10.1089\/sur.2008.043.","journal-title":"Surg Infect (Larchmt)"},{"key":"542_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/jcrc.2001.21795","volume":"16","author":"RM Rodriguez","year":"2001","unstructured":"Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG: Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care. 2001, 16: 36-41. 10.1053\/jcrc.2001.21795.","journal-title":"J Crit Care"},{"key":"542_CR13","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1097\/00003246-200008000-00015","volume":"28","author":"CE van Iperen","year":"2000","unstructured":"van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A: Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med. 2000, 28: 2773-2778. 10.1097\/00003246-200008000-00015.","journal-title":"Crit Care Med"},{"key":"542_CR14","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1097\/00003246-199912000-00005","volume":"27","author":"N von Ahsen","year":"1999","unstructured":"von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU: Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med. 1999, 27: 2630-2639. 10.1097\/00003246-199912000-00005.","journal-title":"Crit Care Med"},{"key":"542_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.compbiomed.2012.11.008","volume":"43","author":"AW Lyon","year":"2013","unstructured":"Lyon AW, Chin AC, Slotsve GA, Lyon ME: Simulation of repetitive diagnostic blood loss and onset of iatrogenic anemia in critical care patients with a mathematical model. Comput Biol Med. 2013, 43: 84-90. 10.1016\/j.compbiomed.2012.11.008.","journal-title":"Comput Biol Med"},{"key":"542_CR16","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1097\/EJA.0b013e32834ad97b","volume":"28","author":"P Piednoir","year":"2011","unstructured":"Piednoir P, Allou N, Driss F, Longrois D, Philip I, Beaumont C, Montravers P, Lasocki S: Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study. Eur J Anaesthesiol. 2011, 28: 796-801. 10.1097\/EJA.0b013e32834ad97b.","journal-title":"Eur J Anaesthesiol"},{"key":"542_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1172\/JCI108489","volume":"58","author":"CA Finch","year":"1976","unstructured":"Finch CA, Miller LR, Inamdar AR, Person R, Seiler K, Mackler B: Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. J Clin Invest. 1976, 58: 447-453. 10.1172\/JCI108489.","journal-title":"J Clin Invest"},{"key":"542_CR18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/jn\/120.8.909","volume":"120","author":"WT Willis","year":"1990","unstructured":"Willis WT, Gohil K, Brooks GA, Dallman PR: Iron deficiency: improved exercise performance within 15 hours of iron treatment in rats. J Nutr. 1990, 120: 909-916.","journal-title":"J Nutr"},{"key":"542_CR19","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1182\/blood-2011-04-346304","volume":"118","author":"PA Krayenbuehl","year":"2011","unstructured":"Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G: Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. 2011, 118: 3222-3227. 10.1182\/blood-2011-04-346304.","journal-title":"Blood"},{"key":"542_CR20","unstructured":"AtlanRea. [www.atlanrea.org]"},{"key":"542_CR21","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators: Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009, 361: 2436-2448. 10.1056\/NEJMoa0908355.","journal-title":"N Engl J Med"},{"key":"542_CR22","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","volume":"31","author":"EA Jankowska","year":"2010","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P: Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010, 31: 1872-1880. 10.1093\/eurheartj\/ehq158.","journal-title":"Eur Heart J"},{"key":"542_CR23","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","volume":"58","author":"DO Okonko","year":"2011","unstructured":"Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA: Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol. 2011, 58: 1241-1251. 10.1016\/j.jacc.2011.04.040.","journal-title":"J Am Coll Cardiol"},{"key":"542_CR24","first-page":"69","volume":"66","author":"V Mathiowetz","year":"1985","unstructured":"Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S: Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil. 1985, 66: 69-74.","journal-title":"Arch Phys Med Rehabil"},{"key":"542_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets EM, Garssen B, Bonke B, De Haes JC: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995, 39: 315-325. 10.1016\/0022-3999(94)00125-O.","journal-title":"J Psychosom Res"},{"key":"542_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1046\/j.1365-2354.2003.00295.x","volume":"12","author":"S Gentile","year":"2003","unstructured":"Gentile S, Delaroziere JC, Favre F, Sambuc R, San Marco JL: Validation of the French 'multidimensional fatigue inventory' (MFI 20). Eur J Cancer Care (Engl). 2003, 12: 58-64. 10.1046\/j.1365-2354.2003.00295.x.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"542_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/cc9992","volume":"15","author":"N Heming","year":"2011","unstructured":"Heming N, Montravers P, Lasocki S: Iron deficiency in critically ill patients: highlighting the role of hepcidin. Crit Care. 2011, 15: 210-10.1186\/cc9992.","journal-title":"Crit Care"},{"key":"542_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/bjh.12311","volume":"161","author":"DW Thomas","year":"2013","unstructured":"Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I: Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol. 2013, 161: 639-648. 10.1111\/bjh.12311.","journal-title":"Br J Haematol"},{"key":"542_CR29","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1515\/CCLM.2009.301","volume":"47","author":"E Urrechaga","year":"2009","unstructured":"Urrechaga E, Borque L, Escanero JF: Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism. Clin Chem Lab Med. 2009, 47: 1411-1416. 10.1515\/CCLM.2009.301.","journal-title":"Clin Chem Lab Med"},{"key":"542_CR30","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1111\/j.1751-553X.2008.01127.x","volume":"32","author":"E Urrechaga","year":"2009","unstructured":"Urrechaga E: The new mature red cell parameter, low haemoglobin density of the Beckman-Coulter LH750: clinical utility in the diagnosis of iron deficiency. Int J Lab Hematol. 2009, 32: e144-e150. 10.1111\/j.1751-553X.2008.01127.x.","journal-title":"Int J Lab Hematol"},{"key":"542_CR31","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1515\/CCLM.2005.207","volume":"43","author":"L Thomas","year":"2005","unstructured":"Thomas L, Franck S, Messinger M, Linssen J, Thome M, Thomas C: Reticulocyte hemoglobin measurement-comparison of two methods in the diagnosis of iron-restricted erythropoiesis. Clin Chem Lab Med. 2005, 43: 1193-1202. 10.1515\/CCLM.2005.207.","journal-title":"Clin Chem Lab Med"},{"key":"542_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1385\/MO:23:1:23","volume":"23","author":"C Thomas","year":"2006","unstructured":"Thomas C, Kirschbaum A, Boehm D, Thomas L: The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy. Med Oncol. 2006, 23: 23-36. 10.1385\/MO:23:1:23.","journal-title":"Med Oncol"},{"key":"542_CR33","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra041809","volume":"352","author":"G Weiss","year":"2005","unstructured":"Weiss G, Goodnough LT: Anemia of chronic disease. N Engl J Med. 2005, 352: 1011-1023. 10.1056\/NEJMra041809.","journal-title":"N Engl J Med"},{"key":"542_CR34","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1097\/CCM.0b013e31818103b9","volume":"36","author":"S Lasocki","year":"2008","unstructured":"Lasocki S, Millot S, Andrieu V, Letteron P, Pilard N, Muzeau F, Thibaudeau O, Montravers P, Beaumont C: Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Crit Care Med. 2008, 36: 2388-2394. 10.1097\/CCM.0b013e31818103b9.","journal-title":"Crit Care Med"},{"key":"542_CR35","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1097\/CCM.0b013e3181a000cf","volume":"37","author":"AP Bateman","year":"2009","unstructured":"Bateman AP, McArdle F, Walsh TS: Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med. 2009, 37: 1906-1912. 10.1097\/CCM.0b013e3181a000cf.","journal-title":"Crit Care Med"},{"key":"542_CR36","doi-asserted-by":"crossref","first-page":"676S","DOI":"10.1093\/jn\/131.2.676S","volume":"131","author":"JD Haas","year":"2001","unstructured":"Haas JD, Brownlie T: Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr. 2001, 131: 676S-688S. discussion 688S-690S","journal-title":"J Nutr"},{"key":"542_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1023\/A:1008978114650","volume":"9","author":"AJ Patterson","year":"2000","unstructured":"Patterson AJ, Brown WJ, Powers JR, Roberts DC: Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women's Health. Qual Life Res. 2000, 9: 491-497. 10.1023\/A:1008978114650.","journal-title":"Qual Life Res"},{"key":"542_CR38","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1097\/01.CCM.0000124878.02614.4C","volume":"32","author":"P Javadi","year":"2004","unstructured":"Javadi P, Buchman TG, Stromberg PE, Husain KD, Dunne WM, Woolsey CA, Turnbull IR, Hotchkiss RS, Karl IE, Coopersmith CM: High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis. Crit Care Med. 2004, 32: 1178-1185. 10.1097\/01.CCM.0000124878.02614.4C.","journal-title":"Crit Care Med"},{"key":"542_CR39","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1097\/CCM.0b013e31824e6713","volume":"40","author":"N Heming","year":"2012","unstructured":"Heming N, Letteron P, Driss F, Millot S, El Benna J, Tourret J, Denamur E, Montravers P, Beaumont C, Lasocki S: Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia. Crit Care Med. 2012, 40: 2141-2148. 10.1097\/CCM.0b013e31824e6713.","journal-title":"Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-014-0542-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-014-0542-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-014-0542-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-014-0542-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:21:05Z","timestamp":1728922865000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-014-0542-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,30]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,10]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1186\/s13054-014-0542-9","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,30]]},"assertion":[{"value":"15 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"542"}}